Physician

Cardiology

Dr. Michael R. Muellerleile, MD


Michael Muellerleile works in the field of Cardiology. He went to medical school at University of Minnesota Medical School. University of Minnesota Medical School has a rank of 40 in research and a 10 in primary care He has 2 awards "Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Michael R. Muellerleile, MD has written publications. He has 1 publication published with PubMed. The lastest paper is: 'Temporal induction of clusterin in the peri-infarct zone after experimental myocardial infarction in the rat.' He accepts Medicare payments and is registered with Medicare.gov.



Publications


Schools


Procedures Preformed


Conditions Treated


Doctors Specialties


Accepted Insurances


Awards


Education


Drug Facts


NPI NUMBER   1255316444
NPPES Provider LastName   MUELLERLEILE
NPPES Provider FirstName   MICHAEL
NPPES Provider ZIPCode   522421009
NPPES Provider State   IA
Specialty Description   Cardiology
Total Claim Count   7828.0
Distinct Opioid Count   3.0
Opioid Claim Count   93.0
Percent Opioid Claims   1.19

Helpful Reviews


Give Anonymous Review


Medicare Facts


National Provider Identifier [NPI] 1255316444
Last Name Of The Provider MUELLERLEILE
First Name Of The Provider MICHAEL
View All

Similar Doctors


Dr. Nicholas W. Hodgman, MD
This Doctor is OpenDoctor Recommended.
Dr. Mohammed E. Khalil, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Keith J. Kopec, MD
This Doctor is OpenDoctor Recommended.
Dr. Michael S. Chandra, MD
This Doctor is OpenDoctor Recommended.
Dr. Weiwei B. Li, MD
Dr. Boothapuri Venkatesh, MD
This Doctor is OpenDoctor Recommended.
Dr. Ryan D. Hollenbeck, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
Dr. Matthew J. McMahon, DO
This Doctor is OpenDoctor Recommended.
Dr. Subhi A. Abu-Halawa, MD
This Doctor is OpenDoctor Recommended.
Dr. Todd O. Noreuil, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications


Doctor Directory | TOS | twitter | FB | Angel | blog